ISRCTN37385347
Completed
Not Applicable
Prospective randomized blinded study evaluating ultrasound versus fluoroscopy guided sacral InterStim® lead placement
Metro Health Hospital0 sites40 target enrollmentJanuary 10, 2017
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Overactive bladder, fecal incontinence
- Sponsor
- Metro Health Hospital
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Diagnosis of overactive bladder, non\-obstructive urinary retention, or fecal incontinence
- •2\. Aged 18 years or older
- •3\. Failure of previous conservative measures (i.e. behavior modification, biofeedback, pelvic floor training, at least one antimuscarinic or beta\-agonist medication)
- •4\. Medically fit to undergo proposed surgery
- •5\. Patient able to consent
Exclusion Criteria
- •1\. Pregnant or planning on becoming pregnant
- •2\. Severe or uncontrolled diabetes with peripheral nerve involvement
- •3\. Knowledge of planned MRI or other procedures precluding implantation of device or need for removal
- •4\. Severe BPH, prostate cancer, urethral stricture, or other mechanical obstruction
- •5\. Active urinary tract, skin, or soft tissue infection
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
To see the effect of training in laparoscopy on the performance of surgery trainees in the operation theatreCTRI/2012/11/003113All India Institute of Medical Sciences20
Completed
Not Applicable
Prospective randomized observer-blinded study comparing the analgesic efficacy of ultrasound-guided rectus sheath block to local anesthetic infiltration for laparoscopic percutaneous extraperitoneal closurelaparoscopic inguinal hernia surgery of children performed under general anesthesiaJPRN-UMIN000020912Hokkaido University34
Not yet recruiting
Phase 2
A Study Comparing two drugs(Granisetron and Ramosetron ) in preventing low blood pressure in pregnant patients undergoing caesarean section under spinal anesthesia using hyperbaric levobupivacaine.Health Condition 1: O30-O48- Maternal care related to the fetus and amniotic cavity and possible delivery problemsHealth Condition 2: O00-O9A- Pregnancy, childbirth and the puerperiumCTRI/2024/03/063785Department of anaesthesiology
Active, not recruiting
Not Applicable
A Randomized, Partially-blind Study to Evaluate the Safety, Tolerability and Effect on Virological Response of Treatment with the HCV Protease Inhibitor RO5190591 in Combinationwith Pegasys and Copegus for 12 or 24 weeks, versus treatment with Pegasys and Copegus alone, in Treatment-Na?ve Patients with Chronic Hepatitis C Genotype 1 Virus Infection. - NDChronic Hepatitis C (CHC) Genotype 1MedDRA version: 12.0Level: LLTClassification code 10008912Term: Chronic hepatitis CEUCTR2009-009608-38-ITF.Hoffmann-La Roche300
Active, not recruiting
Phase 1
A Randomized, Partially-blind Study to Evaluate the Safety, Tolerability and Effect on Virological Response of Treatment with the HCV Protease Inhibitor RO5190591 in combination with Pegasys and Copegus for 12 or 24 weeks, versus treatment with Pegasys and Copegus alone, in Treatment-Naïve Patients with Chronic Hepatitis C Genotype 1 Virus InfectioEUCTR2009-009608-38-FRF.Hoffmann-La Roche300